Anna Azvolinsky - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Anna Azvolinsky's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Anna Azvolinsky
Verified
Journalist, Freelance
New York
Beats
Medical Science , Neuro Endocrine, Psych, Hiking , Strength Training , Cardio, Fertility
Desenvolvimento, programação, redação
Content
By Anna Azvolinsky Verified| Cancer Today Verified TREATMENTS FOR PEOPLE with multiple myeloma, a type of blood cancer that occurs in the plasma cells of the bone, have extended many patients’ lives. But even in cases where people have a complete response—showing no signs of cancer on imaging or in blood and urine tests—the cancer can return. That’s because multiple myeloma is incurable, and most people with the disease go through cycles of remissions and relapse, followed by rounds of treatment to keep the cancer at bay.
By Anna Azvolinsky Verified| Cancer Today Verified PEOPLE WITH MELANOMA who receive immunotherapy typically undergo an 18F-fluorodeoxyglucose (FDG) PET/CT scan about three months after starting treatment to see whether their tumors are responding. A study published May 1, 2024, in Clinical Cancer Research has found FDG PET/CT—one of the most readily available ways to detect cancer—can reveal responses to immunotherapy just one week after people with metastatic melanoma begin treatment.
By Anna Azvolinsky Verified| Cancer Today Verified TREATMENTS FOR PEOPLE with multiple myeloma, a type of blood cancer that occurs in the plasma cells of the bone, have extended many patients’ lives. But even in cases where people have a complete response—showing no signs of cancer on imaging or in blood and urine tests—the cancer can return. That’s because multiple myeloma is incurable, and most people with the disease go through cycles of remissions and relapse, followed by rounds of treatment to keep the cancer at bay.
Company Info
Freelance
Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.
De Pere, Wisconsin, United States